首页> 外文OA文献 >A Retrospective Survival Analysis of Anatomic and Prognostic Stage Group Based on the American Joint Committee on Cancer 8th Edition Cancer Staging Manual in Luminal B Human Epidermal Growth Factor Receptor 2-negative Breast Cancer

【2h】

A Retrospective Survival Analysis of Anatomic and Prognostic Stage Group Based on the American Joint Committee on Cancer 8th Edition Cancer Staging Manual in Luminal B Human Epidermal Growth Factor Receptor 2-negative Breast Cancer

机译：基于美国肿瘤联合委员会第8版癌症分期手册Luminal B人类表皮生长因子受体2阴性乳腺癌的解剖和预后阶段组的回顾性生存分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Ling Xu; Jiang-Hong Li; Jing-Ming Ye; Xue-Ning Duan; Yuan-Jia Cheng; Ling Xin; Qian Liu; Bin Zhou; Yin-Hua Liu;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A Retrospective Survival Analysis of Anatomic and Prognostic Stage Group Based on the American Joint Committee on Cancer 8th Edition Cancer Staging Manual in Luminal B Human Epidermal Growth Factor Receptor 2?negative Breast Cancer [J] . Ling Xu, Jiang‑Hong Li, Jing‑Ming Ye, 中华医学杂志（英文版） . 2017,第016期

机译：基于美国癌症联合委员会第8版发光B型人类表皮生长因子受体2阴性乳腺癌的癌症分期手册对解剖和预后阶段组进行回顾性生存分析。
2. Evaluation of the Incorporation of Recurrence Score into the American Joint Committee on Cancer Eighth Edition Staging System in Patients with T1-2N0M0, Estrogen Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Invasive Breast Cancer: A Population-Based Analysis [J] . Shuning Ding, Jiayi Wu, Caijin Lin, The oncologist . 2019,第11期

机译：在T1-2N0M0，雌激素受体阳性，人体表皮生长受体2阴性侵袭性乳腺癌中将复发评分纳入美国联合委员会纳入美国联合委员会的评估：基于人群的分析
3. Evaluation of the Incorporation of Recurrence Score into the American Joint Committee on Cancer Eighth Edition Staging System in Patients with T1‐2N0M0, Estrogen Receptor‐Positive, Human Epidermal Growth Receptor 2‐Negative Invasive Breast Cancer: A Population‐Based Analysis [J] . Ding Shuning, Wu Jiayi, Lin Caijin, The oncologist . 2019,第11期

机译：在T1-2N0M0，雌激素受体阳性，人体表皮生长受体2阴性侵袭性乳腺癌中将复发评分纳入美国联合委员会纳入美国联合委员会的评估：基于人群的分析
4. Identification of Human Epidermal Growth Factor Receptor 2 Antagonist In Silico for Breast Cancer Therapy, Derived from Indonesian Phytochemicals [C] . Tuti Ratnasari, Dono indarto, Raden Ajeng Sri Wulandari, International Conference on Biomedical Engineering . 2018

机译：人类表皮生长因子受体2拮抗剂在二氧化硅中用于印尼治疗的印尼植物化学成分的鉴定。
5. Indirect Costs Associated with Human Epidermal Growth Factor Receptor Positive (HER2+) Metastatic Breast Cancer [D] . Wright, Phoebe. 2020

机译：与人表皮生长因子受体阳性（HER2 +）转移性乳腺癌相关的间接成本
6. A Retrospective Survival Analysis of Anatomic and Prognostic Stage Group Based on the American Joint Committee on Cancer 8th Edition Cancer Staging Manual in Luminal B Human Epidermal Growth Factor Receptor 2-negative Breast Cancer [O] . Ling Xu, Jiang-Hong Li, Jing-Ming Ye, 2017

机译：基于美国癌症联合委员会第8版Luminal B人表皮生长因子受体2阴性乳腺癌的癌症分期手册对解剖和预后阶段组进行回顾性生存分析。
7. A retrospective prognostic evaluation analysis using the 8th edition of American Joint Committee on Cancer (AJCC) cancer staging system for luminal A breast cancer [O] . Jingming Ye, Wenjun Wang, Ling Xu, 2017

机译：第8版美国癌症（AJCC）癌症癌症癌症癌症癌症委员会第8版的回顾性预后评价分析

A Retrospective Survival Analysis of Anatomic and Prognostic Stage Group Based on the American Joint Committee on Cancer 8th Edition Cancer Staging Manual in Luminal B Human Epidermal Growth Factor Receptor 2-negative Breast Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅